Electrospun,synthetic bone void filler promotes human MSC function and BMP-2 mediated spinal fusion

Abstract

Introduction

Synthetic bone grafts are often used to achieve a well-consolidated fusion mass in spinal fusion procedures. These bone grafts function as scaffolds, and ideally support cell function and facilitate protein binding.

Objective

The aim was to characterize an electrospun, synthetic bone void filler (Reb) for its bone morphogenetic protein (BMP)-2 release properties and support of human mesenchymal stem cell (hMSC) function in vitro, and its efficacy in promoting BMP-2-/bone marrow aspirate-(BMA)-mediated posterolateral spinal fusion (PLF) in vivo.

Methods

BMP-2 release kinetics from Reb versus standard absorbable collagen sponge (ACS) was determined. hMSC adhesion and proliferation on Reb was tested using cell counting, fluorescence microscopy and MTS. Cell osteogenic differentiation was quantified via cellular alkaline phosphatase (ALP) activity. For in vivo analysis, 18 Lewis rats were treated during PLF surgery with the following groups: (I) Reb + BMA, (II) Reb + BMA + BMP-2 and (III) BMA. A safe, minimally effective dose of BMP-2 was used. Fusion consolidation was followed for 3 months using radiography and micro-CT. After sacrifice, fusion rate and biomechanical stiffness was determined using manual palpation, biomechanical tests and histology.

Results

In vitro, BMP-2 release kinetics were similar between Reb versus ACS. MSC proliferation and differentiation were increased in the presence of Reb. At 3 months post-surgery, fusion rates were 29% (group I), 100% (group II), and 0% (group III). Biomechanical stiffness was higher in group II versus I. Micro-CT showed an increased bone volume and connectivity density in group II. Trabecular thickness was increased in group I versus II. H&E staining showed newly formed bone in group II only.

Conclusions

Reb possesses a high protein binding affinity and promotes hMSC function. Combination with BMA and minimal dose BMP-2 allowed for 100% bone fusion in vivo. This data suggests that a minimally effective dose of BMP-2 can be used when combined with Reb.

Keywords

Synthetic bone carrier electrospinning recombinant human bone morphogenetic protein mesenchymal stem cells bone healing

Get full access to this article

View all access options for this article.

References

Chaput

CD.

Optimization of scaffolds and surface-based treatments for orthopedic applications. Spine (Phila Pa 1976) 2016; 41: S14–S15.

Ghassemi

Shahroodi

Ebrahimzadeh

, et al. Current concepts in scaffolding for bone tissue engineering. Arch Bone Jt Surg 2018; 6: 90–99.

Cunningham

Atkinson

, et al. Ceramic granules enhanced with B2A peptide for lumbar interbody spine fusion: an experimental study using an instrumented model in sheep. J Neurosurg Spine 2009; 10: 300–307.

Rossi

Santoro

Perale

Polymeric scaffolds as stem cell carriers in bone repair. J Tissue Eng Regen Med 2015; 9: 1093–1119.

Zeng

Liu

Xiong

, et al. Scaffolds for the repair of bone defects in clinical studies: a systematic review. J Orthop Surg Res 2018; 13: 33.

Khashan

Inoue

Berven

SH.

Cell based therapies as compared to autologous bone grafts for spinal arthrodesis. Spine 2013; 38: 1885–1891.

Kunakornsawat

Kirinpanu

Piyaskulkaew

, et al. A comparative study of radiographic results using HEALOS collagen-hydroxyapatite sponge with bone marrow aspiration versus local bone graft in the same patients undergoing posterolateral lumbar fusion. J Med Assoc Thai 2013; 96: 929–935.

Lykissas

Gkiatas

Use of recombinant human bone morphogenetic protein-2 in spine surgery. World J Orthop 2017; 8: 531–535.

Hustedt

Blizzard

DJ.

The controversy surrounding bone morphogenetic proteins in the spine: a review of current research. Yale J Biol Med 2014; 87: 549–561.

10.

Yang

Cho

, et al. Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Exp Mol Med 2012; 44: 350–355.

11.

Glaeser

Salehi

Kanim

LEA

, et al. Anti-inflammatory peptide attenuates edema and promotes BMP-2-induced bone formation in spine fusion. Tissue Eng Part A 2018; 24: 1641–1651.

12.

Lord

Cohen

Buser

, et al. Trends, costs, and complications of anterior cervical discectomy and fusion with and without bone morphogenetic protein in the United States Medicare population. Global Spine J 2017; 7: 603–608.

13.

Shields

Raque

Glassman

, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006; 31: 542–547.

14.

Shang

Qiao

Hao

, et al. bFGF-sodium hyaluronate collagen scaffolds enable the formation of nascent neural networks after adult spinal cord injury. J Biomed Nanotechnol 2019; 15: 703–716.

15.

Agrawal

Sinha

A review on carrier systems for bone morphogenetic protein-2. J Biomed Mater Res Part B Appl Biomater 2017; 105: 904–925.

16.

Prabhakaran

Venugopal

Ramakrishna

Electrospun nanostructured scaffolds for bone tissue engineering. Acta Biomater 2009; 5: 2884–2893.

17.

Jiang

Heng

Huang

, et al. Biomimetic poly(poly(epsilon-caprolactone)-polytetrahydrofuran urethane) based nanofibers enhanced chondrogenic differentiation and cartilage regeneration. J Biomed Nanotechnol 2019; 15: 1005–1017.

18.

Wang

Chu

, et al. Injectable and thermosensitive hydrogel and PDLLA electrospun nanofiber membrane composites for guided spinal fusion. ACS Appl Mater Interfaces 2018; 10: 4462–4470.

19.

Bhattarai

Aguilar

Park

, et al. A review on properties of natural and synthetic based electrospun fibrous materials for bone tissue engineering. Membranes (Basel) 2018; 8: 62.

20.

Sill

von Recum

HA.

Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008; 29: 1989–2006.

21.

Mehrasa

Asadollahi

Ghaedi

Salehi

, et al. Electrospun aligned PLGA and PLGA/gelatin nanofibers embedded with silica nanoparticles for tissue engineering. Int J Biol Macromol 2015; 79: 687–695.

22.

Bae

Zhao

Kanim

, et al. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model. J Bone Joint Surg Am 2013; 95: 338–347.

23.

Seebach

Schultheiss

Wilhelm

, et al. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro. Injury 2010; 41: 731–738.

24.

Vater

Kasten

Stiehler

Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 2011; 7: 463–477.

25.

Cao

Xiao

Cao

, et al. 3D printed beta-TCP scaffold with sphingosine 1-phosphate coating promotes osteogenesis and inhibits inflammation. Biochem Biophys Res Commun 2019; 512: 889–895.

26.

Metzger

Kanim

Zhao

, et al. The relationship between serum vitamin D levels and spinal fusion success: a quantitative analysis. Spine (Phila Pa 1976) 2015; 40: E458–E468.

27.

Robinson

Svet

Kanim

, et al. Four-point bending as a method for quantitatively evaluating spinal arthrodesis in a rat model. Comp Med 2015; 65: 46–50.

28.

Einhorn

Gerstenfeld

LC.

Fracture healing: mechanisms and interventions. Nat Rev Rheumatol 2015; 11: 45–54.

29.

Maus

Andereya

Gravius

, et al. Lack of effect on bone healing of injectable BMP-2 augmented hyaluronic acid. Arch Orthop Trauma Surg 2008; 128: 1461–1466.

30.

Seo

Choi

Koh

, et al. Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with BMP-2. J Control Release 2015; 209: 67–76.

31.

Olthof

MGL

Kempen

DHR

Liu

, et al. Bone morphogenetic protein-2 release profile modulates bone formation in phosphorylated hydrogel. J Tissue Eng Regen Med 2018; 12: 1339–1351.

32.

Suliman

Xing

, et al. Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo. J Control Release 2015; 197: 148–157.

33.

Schultheiss

Seebach

Henrich

, et al. Mesenchymal stem cell (MSC) and endothelial progenitor cell (EPC) growth and adhesion in six different bone graft substitutes. Eur J Trauma Emerg Surg 2011; 37: 635–644.

34.

Yoshimoto

Shin

Terai

, et al. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003; 24: 2077–2082.

35.

James

LaChaud

Shen

, et al. A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B Rev 2016; 22: 284–297.

36.

Liu

Lam

WMR

Naidu

, et al. Synergistic effect of NELL-1 and an ultra-low dose of BMP-2 on spinal fusion. Tissue Eng Part A 2019; 25: 1677–1689.

37.

Lee

Murray

Taghavi

, et al. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine J 2011; 11: 568–576.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.07 MB